PROCTER & GAMBLE Co (PG) Form 424B5 — Oct 27, 2026
Procter & Gamble filed a preliminary prospectus supplement (424B5) for a euro-denominated notes offering across four tranches, with coupon rates, maturities, and principal amounts blanked pending pricing. The notes will be issued in denominations of €100,000 with application for NYSE listing. The filing discloses P&G's capitalization as of September 30, 2026: total debt of $38.9 billion, total capitalization of $94.3 billion, and $8.0 billion of undrawn bank credit lines. P&G also plans a separate $4.0 billion USD notes issuance expected on October 30, 2026.
Key figures
- Total Debt
- 38925000000
- Long term debt
- $21,897 million
- Note denominations
- €100,000 and integral multiples of €1,000
- Total capitalization
- $94,262 million
- Debt due within one year
- $17,028 million
- Bank credit lines undrawn
- $8.0 billion
- Total shareholders equity
- $55,337 million
- Additional usd notes planned
- $4.0 billion expected to be issued October 30, 2026
- Diluted weighted avg shares q1 fy27
- 2,407.2 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.